Medtronic (MDT) exec says dividend is not getting in way of M&A and no change in dividend policy

• Co. has significant firepower with balance sheet to carry out meaningful number of acquisitions without any problem.
• What's changing versus last few years is coming back to doing more M&A.

Medtronic's commitment to its dividend policy suggests financial stability, which could allow for aggressive M&A activity without harming shareholder returns. This signals a strategic pivot back towards acquisitions, leveraging its strong balance sheet—potentially increasing competitive positioning in the health care sector. Market participants may view this as a positive indicator for growth, particularly if further acquisitions align with Medtronic’s long-term goals.